Abcellera Biologics Inc (ABCL) Stock Price, Quote & News

Company Profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a researc...

Industry: Biotechnology

Sector: Healthcare

Phone: 604 559 9005

Website: www.abcellera.com

Address:

150 W 4th Avenue, Vancouver, Canada

Odoji Apr. 27 at 6:28 PM

$ABCL 💉

1 · Reply

DeMampCamp Apr. 27 at 4:12 PM

$ABCL Wow, frustrating! I’ve been watching other small caps and it looks like the ones I’ve been looking at have all dropped dramatically from their early morning highs, I’m not really sure what’s going on

1 · Reply

Targhee Apr. 27 at 3:45 PM

$ABCL

1 · Reply

JennyRowes Apr. 27 at 3:18 PM

$ABCL already 3.4M shares??!!

2 · Reply

tradersunion353 Apr. 27 at 2:28 PM

$ABCL This is what it happens when the company talks too much positive and under deliver.. Bearish talk has started for stock being undeperformed for so long.... POS cannot even trade properly at book values.. Adders and loaders floor is yours once the stock turns RED 🤣

1 · Reply

DeMampCamp Apr. 27 at 1:53 PM

$ABCL

0 · Reply

Odoji Apr. 27 at 1:48 PM

$ABCL 💉

0 · Reply

bonecrack_benny Apr. 27 at 1:39 PM

$ABCL

0 · Reply

Ckkung71 Apr. 27 at 1:26 PM

$ABCL What ever you do don’t sell then they try to push it down…..

0 · Reply

8008track Apr. 27 at 4:17 AM

$ABCL looking forward to the next couple of weeks

2 · Reply

AbCellera Biologics Transcript: 2026 Bloom Burton & Co. Healthcare Investor Conference

Apr 20, 2026, 9:00 AM EDT - 7 days ago

AbCellera to Highlight Phase 1 Clinical Data for ABCL635 During Upcoming First Quarter 2026 Earnings Call

Apr 1, 2026, 4:05 PM EDT - 25 days ago

AbCellera to Report First Quarter 2026 Financial Results on May 11, 2026

Mar 17, 2026, 4:30 PM EDT - 5 weeks ago

AbCellera Biologics Transcript: 2026 KeyBanc Capital Markets Healthcare Forum

Mar 4, 2026, 9:50 AM EST - 7 weeks ago

AbCellera Biologics Transcript: TD Cowen 46th Annual Health Care Conference

Feb 24, 2026, 5:00 PM EST - 2 months ago

AbCellera Biologics Earnings Call Transcript: Q4 2025

Feb 24, 2026, 4:05 PM EST - 2 months ago

AbCellera Reports Full Year 2025 Business Results

Feb 11, 2026, 4:05 PM EST - 2 months ago

AbCellera to Present at Upcoming Investor Conferences in March and April 2026

Jan 22, 2026, 4:05 PM EST - 3 months ago

AbCellera to Report Full Year 2025 Financial Results on February 24, 2026

Jan 14, 2026, 6:45 PM EST - 3 months ago

AbCellera Biologics Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 9:00 AM EST - 3 months ago

AbCellera Announces First Patients Dosed in Phase 2 Portion of its Phase 1/2 Clinical Trial of ABCL635 for the Treatment of Vasomotor Symptoms Due to Menopause

Dec 18, 2025, 9:00 AM EST - 4 months ago

AbCellera and Bruker Reach Global Settlement of Patent Litigation

Dec 8, 2025, 4:05 PM EST - 4 months ago

AbCellera to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026

Dec 3, 2025, 8:00 AM EST - 5 months ago

AbCellera Biologics Transcript: Piper Sandler 37th Annual Healthcare Conference

Nov 13, 2025, 8:00 AM EST - 5 months ago

AbCellera Biologics Transcript: Stifel 2025 Healthcare Conference

Nov 10, 2025, 9:00 AM EST - 6 months ago

AbCellera Appoints Dr. Stephen Quake to its Board of Directors

Nov 6, 2025, 5:00 PM EST - 6 months ago

AbCellera Biologics Earnings Call Transcript: Q3 2025

Nov 6, 2025, 4:05 PM EST - 6 months ago

AbCellera Reports Q3 2025 Business Results

Oct 7, 2025, 4:05 PM EDT - 7 months ago

AbCellera to Participate at Upcoming Investor Conferences in November and December 2025

Sep 29, 2025, 4:05 PM EDT - 7 months ago

AbCellera to Report Third Quarter 2025 Financial Results on November 6, 2025

Sep 10, 2025, 9:07 AM EDT - 8 months ago

AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer

Sep 5, 2025, 9:30 AM EDT - 8 months ago

AbCellera Biologics Transcript: Wells Fargo 20th Annual Healthcare Conference 2025

Aug 27, 2025, 9:00 AM EDT - 8 months ago

AbCellera Doses First Participants in a Phase 1 Clinical Trial of ABCL575

Aug 12, 2025, 4:05 PM EDT - 9 months ago

AbCellera to Participate at Upcoming Investor Conferences in September

Aug 7, 2025, 5:00 PM EDT - 9 months ago

AbCellera Biologics Earnings Call Transcript: Q2 2025

Aug 7, 2025, 4:05 PM EDT - 9 months ago

AbCellera Reports Q2 2025 Business Results & First Participants Dosed in a Phase 1 Clinical Trial of ABCL635 for Vasomotor Symptoms

Jul 7, 2025, 4:05 PM EDT - 10 months ago

AbCellera to Report Second Quarter 2025 Financial Results on August 7, 2025

Jun 9, 2025, 10:40 AM EDT - 11 months ago

AbCellera Biologics Transcript: Goldman Sachs 46th Annual Global Healthcare Conference

May 30, 2025, 1:00 PM EDT - 11 months ago

AbCellera Receives Authorization from Health Canada to Initiate a Phase 1 Clinical Trial of ABCL575

May 14, 2025, 5:00 PM EDT - 1 year ago

AbCellera Receives Authorization from Health Canada to Initiate the Phase 1 Clinical Trial of ABCL635 for Vasomotor Symptoms Due to Menopause

May 12, 2025, 3:30 PM EDT - 1 year ago

AbCellera's Microfluidic Cell Culture Patent Affirmed Valid by the U.S. Court of Appeals for the Federal Circuit

May 9, 2025, 7:30 PM EDT - 1 year ago

AbCellera Presents Positive Preclinical Data on ABCL575 at the 2025 SID Annual Meeting

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q1 2025

May 8, 2025, 4:05 PM EDT - 1 year ago

AbCellera Reports Q1 2025 Business Results

May 5, 2025, 9:30 AM EDT - 1 year ago

AbCellera Biologics Transcript: Bloom Burton & Co. Healthcare Investor Conference 2025

Apr 29, 2025, 3:00 PM EDT - 1 year ago

AbCellera Presents Data Showing Preclinical Efficacy of PSMA x CD3 T-Cell Engagers at AACR 2025

Apr 8, 2025, 4:05 PM EDT - 1 year ago

AbCellera to Participate at Upcoming Investor Conferences in May and June

Apr 3, 2025, 4:05 PM EDT - 1 year ago

AbCellera to Report First Quarter 2025 Financial Results on May 8, 2025

Mar 25, 2025, 4:30 PM EDT - 1 year ago

AbCellera Announces Presentation of In Vivo Data on PSMA x CD3 T-Cell Engagers at AACR 2025

Mar 19, 2025, 1:30 PM EDT - 1 year ago

AbCellera Biologics Transcript: KeyBanc Annual Health Care Forum

Mar 3, 2025, 2:30 PM EST - 1 year ago

AbCellera Biologics Transcript: TD Cowen 45th Annual Healthcare Conference

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q4 2024

Feb 27, 2025, 4:05 PM EST - 1 year ago

AbCellera Reports Full Year 2024 Business Results

Feb 11, 2025, 4:05 PM EST - 1 year ago

AbCellera to Participate at Upcoming Investor Conferences in March

Jan 21, 2025, 4:05 PM EST - 1 year ago

AbCellera to Report Full Year 2024 Financial Results on February 27, 2025

Jan 15, 2025, 7:30 PM EST - 1 year ago

AbCellera Biologics Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025

Jan 13, 2025, 9:00 AM EST - 1 year ago

AbCellera Expands Collaboration with AbbVie to Develop Novel T-Cell Engagers for Oncology

Dec 3, 2024, 2:30 PM EST - 1 year ago

AbCellera Biologics Transcript: Piper Sandler 36th Annual Healthcare Conference

Nov 21, 2024, 4:05 PM EST - 1 year ago

AbCellera to Present at Upcoming Investor Conferences in December and January

Nov 19, 2024, 11:30 AM EST - 1 year ago

AbCellera Biologics Transcript: Jefferies London Healthcare Conference 2024

Nov 18, 2024, 11:30 AM EST - 1 year ago

AbCellera Biologics Transcript: Stifel 2024 Healthcare Conference

Nov 7, 2024, 10:05 AM EST - 1 year ago

AbCellera Presents Data on Applications of T-Cell Engager Platform at SITC 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q3 2024

Nov 4, 2024, 4:05 PM EST - 1 year ago

AbCellera Reports Q3 2024 Business Results

Oct 22, 2024, 4:05 PM EDT - 1 year ago

AbCellera to Present at Upcoming Investor Conferences in November 2024

Oct 4, 2024, 9:00 AM EDT - 1 year ago

AbCellera Announces Presentation on T-cell Engager Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024

Sep 26, 2024, 4:05 PM EDT - 1 year ago

AbCellera to Report Third Quarter 2024 Financial Results on November 4, 2024

Sep 17, 2024, 11:30 AM EDT - 1 year ago

AbCellera Biologics Transcript: 2024 Cantor Fitzgerald Global Healthcare Conference

Sep 5, 2024, 3:00 PM EDT - 1 year ago

AbCellera Biologics Transcript: 2024 Wells Fargo Healthcare Conference

Aug 29, 2024, 4:05 PM EDT - 1 year ago

AbCellera to Present at Upcoming Investor Conferences in September

Aug 20, 2024, 9:45 AM EDT - 1 year ago

This Globant Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

GLOB AVDX LRN PGRU

Aug 6, 2024, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q2 2024

Aug 6, 2024, 4:05 PM EDT - 1 year ago

AbCellera Reports Q2 2024 Business Results

Jul 31, 2024, 9:00 AM EDT - 1 year ago

AbCellera and Lilly Expand Collaboration to Develop Antibody Medicines

Jun 25, 2024, 4:05 PM EDT - 1 year ago

AbCellera to Report Second Quarter 2024 Financial Results on August 6, 2024

Jun 10, 2024, 3:20 PM EDT - 2 years ago

AbCellera Biologics Transcript: Goldman Sachs 45th Annual Global Healthcare Conference

May 28, 2024, 4:05 PM EDT - 2 years ago

AbCellera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings Call Transcript: Q1 2024

May 7, 2024, 4:05 PM EDT - 2 years ago

AbCellera Reports Q1 2024 Business Results

May 1, 2024, 9:00 AM EDT - 2 years ago

AbCellera, Viking Global Investors, and ArrowMark Partners Collaborate to Launch New Biotech Companies

Apr 16, 2024, 10:00 AM EDT - 2 years ago

AbCellera Biologics Transcript: Bloom Burton & Co. Healthcare Investor Conference

Apr 8, 2024, 12:05 PM EDT - 2 years ago

AbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024

Apr 3, 2024, 4:05 PM EDT - 2 years ago

AbCellera to Report First Quarter 2024 Financial Results on May 7, 2024

Mar 20, 2024, 11:15 AM EDT - 2 years ago

AbCellera Biologics Transcript: KeyBanc Capital Markets Life Sciences & MedTech Investor Forum

Mar 19, 2024, 4:05 PM EDT - 2 years ago

AbCellera to Present at the Bloom Burton Healthcare Conference on April 16, 2024

Mar 11, 2024, 9:00 AM EDT - 2 years ago

AbCellera to Collaborate with Biogen to Discover Therapeutic Antibodies for Neurological Conditions

BIIB

Mar 5, 2024, 4:30 PM EST - 2 years ago

AbCellera Announces Four Presentations on T-Cell Engagers at AACR 2024

Mar 5, 2024, 2:50 PM EST - 2 years ago

AbCellera Biologics Transcript: TD Cowen 44th Annual Health Care Conference 2024

Feb 23, 2024, 4:30 PM EST - 2 years ago

AbCellera Announces Resignation of Board Member

Feb 20, 2024, 5:00 PM EST - 2 years ago

AbCellera Biologics Earnings Call Transcript: Q4 2023

Jan 10, 2024, 5:15 PM EST - 2 years ago

AbCellera Biologics Transcript: J.P. Morgan 42nd Annual Healthcare Conference 2024

Nov 30, 2023, 9:30 AM EST - 2 years ago

AbCellera Biologics Transcript: Piper Sandler 35th Annual Healthcare Conference

Nov 14, 2023, 11:30 AM EST - 2 years ago

AbCellera Biologics Transcript: Jefferies London Healthcare Conference 2023

Nov 2, 2023, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings Call Transcript: Q3 2023

Aug 3, 2023, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings Call Transcript: Q2 2023

Jun 13, 2023, 4:20 PM EDT - 3 years ago

AbCellera Biologics Transcript: Goldman Sachs 44th Annual Global Healthcare Conference

May 4, 2023, 5:00 PM EDT - 3 years ago

AbCellera Biologics Earnings Call Transcript: Q1 2023

Feb 21, 2023, 5:00 PM EST - 3 years ago

AbCellera Biologics Earnings Call Transcript: Q4 2022

Jan 11, 2023, 5:15 PM EST - 3 years ago

AbCellera Biologics Transcript: JPMorgan Healthcare Conference

Nov 8, 2022, 5:00 PM EST - 3 years ago

AbCellera Biologics Earnings Call Transcript: Q3 2022

Aug 9, 2022, 5:00 PM EDT - 4 years ago

AbCellera Biologics Earnings Call Transcript: Q2 2022

May 10, 2022, 8:52 AM EDT - 4 years ago

AbCellera Biologics Earnings Call Transcript: Q1 2022

Feb 24, 2022, 9:23 AM EST - 4 years ago

AbCellera Biologics Earnings Call Transcript: Q4 2021

Nov 8, 2021, 7:00 PM EST - 4 years ago

AbCellera Biologics Earnings Call Transcript: Q3 2021

Aug 12, 2021, 12:02 PM EDT - 5 years ago

AbCellera Biologics Earnings Call Transcript: Q2 2021

May 13, 2021, 9:46 AM EDT - 5 years ago

AbCellera Biologics Earnings Call Transcript: Q1 2021

Mar 29, 2021, 9:46 AM EDT - 5 years ago

AbCellera Biologics Earnings Call Transcript: Q4 2020

Odoji Apr. 27 at 6:28 PM

$ABCL 💉

1 · Reply

DeMampCamp Apr. 27 at 4:12 PM

1 · Reply

Targhee Apr. 27 at 3:45 PM

$ABCL

1 · Reply

JennyRowes Apr. 27 at 3:18 PM

$ABCL already 3.4M shares??!!

2 · Reply

tradersunion353 Apr. 27 at 2:28 PM

1 · Reply

DeMampCamp Apr. 27 at 1:53 PM

$ABCL

0 · Reply

Odoji Apr. 27 at 1:48 PM

$ABCL 💉

0 · Reply

bonecrack_benny Apr. 27 at 1:39 PM

$ABCL

0 · Reply

Ckkung71 Apr. 27 at 1:26 PM

$ABCL What ever you do don’t sell then they try to push it down…..

0 · Reply

8008track Apr. 27 at 4:17 AM

$ABCL looking forward to the next couple of weeks

2 · Reply

DragonAlgo Apr. 26 at 3:40 PM

🐉 $ABCL CALL — DragonAlgo® Signal Contract: ABCL CALL Expiry: 2026-07-17 | Strike: $5.00 | Type: CALL Option Plan (premium): Entry: $0.53 Stop: $0.38 TP1: $0.68 TP2: $0.89 TP3: $1.26 🔗 https://dragonalgo.com

0 · Reply

UncleTomFlorida Apr. 25 at 2:56 PM

$ABCL $IBRX Chemo a conflict of interest? https://x.com/bullishbruk/status/2047779809909002506?s=20

0 · Reply

UncleTomFlorida Apr. 25 at 2:15 PM

$ABCL

0 · Reply

UncleTomFlorida Apr. 25 at 4:35 AM

$ABCL $40 by ……? https://x.com/JackPrescottX/status/2047791083686682864?s=20

0 · Reply

DeMampCamp Apr. 24 at 8:12 PM

$ABCL I'm happy that we closed above the 200ma, but less than thrilled that they hammered it down from $4.29. Over 9.3 million in volume today, I'm looking for $5+ next week if the overall markets can cooperate! Cheers everyone, have a wonderful weekend!

2 · Reply

bonecrack_benny Apr. 24 at 6:43 PM

$ABCL Amazing.

1 · Reply

Art_BunyaaHa Apr. 24 at 6:28 PM

$ABCL

0 · Reply

JennyRowes Apr. 24 at 5:59 PM

$ABCL higher and higher on higher volume.

0 · Reply

DeMampCamp Apr. 24 at 5:50 PM

$ABCL Shorts trying so hard to not let this get out of hand!

1 · Reply

NorthShoreTrader2021 Apr. 24 at 5:49 PM

$ABCL Imagine shorting $ABCL and watching it keep climbing day after day. 📈 That's the reality for shorts right now — significant losses piling up as AbCellera's price grinds higher and they refuse to cover. Every uptick is a squeeze tightening around their positions. Check the $ABCL charts. The price action speaks for itself. Shorts are on the wrong side of this trade and the pressure is only building. 🔥

1 · Reply

tradersunion353 Apr. 24 at 5:30 PM

$ABCL Yes you need to keep moving up.. you need to benefit long term investors... Ned $12 please..

1 · Reply

Ckkung71 Apr. 24 at 4:55 PM

$ABCL up,down,up,down,up,down…

0 · Reply

Market Cap	1.26B
Revenue (ttm)	75.13M
Net Income (ttm)	-146.41M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-194.88%
Debt to Equity Ratio	0.00

Volume	7,507,455
Avg Vol	3,425,978
Day's Range	N/A - N/A
Shares Out	303.16M
Stochastic %K	76%
Beta	0.85
Analysts	Strong Sell
Price Target	$9.43